Investors in Lifescience

Accelerate@Babraham is the incubation programme of the Babraham Research Campus. One of the best places in Europe to start-up and scale-up a life science business. The Babraham Research Campus is considered to be the UK’s leading campus to support early-stage bioscience enterprise and is distinct in its co-location of bioscience companies with the Babraham Institute, a world-renowned research organisation.

Ruffena Capital specializes in financing and capital investment advisory services. As a trusted advisor, Ruffena Capital assists clients in navigating the complexities of capital raising and investment strategies. They provide tailored financial solutions and strategic guidance to businesses seeking growth capital, leveraging their expertise to optimize funding opportunities and drive sustainable business development. Ruffena Capital's commitment lies in facilitating successful capital transactions and fostering long-term partnerships with their clients.

HS LifeSciences was established in 2008 by seasoned biotech entrepreneurs with many years of experience in managing biotech companies. The lessons learned over the years have been distilled into a new business model centered on the foundation and growth of new life sciences companies without the need for conventional multiple rounds of equity-based financing.

Namarel Ventures is an early-stage investment firm focusing on the healthcare sector, specializing in supporting innovative, data-driven companies in medical devices, diagnostics, and digital health. They seek out committed entrepreneurs who share their vision of addressing unmet medical needs and advancing towards market success. Namarel Ventures prioritizes active involvement in projects where their expertise and experience can make a significant impact on the healthcare sector. While they do not have geographic constraints, their primary focus for investments is within Spain.